CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 4 Open-market sale SVP Reg. & Quality sold 19,059 shares at $7.00 ($133,417)
- 8-K Event Material agreement · New debt or obligation
- 4 Option exercise Chief Scientific Officer acquired 5,000 shares (option exercise)
- 4 Option exercise Chief Scientific Officer acquired 40,000 shares (option exercise)
- 4 Open-market sale Director sold 25,000 shares at $7.54 ($188,430)
- 4 Open-market sale SVP Reg. & Quality sold 110,000 shares at $7.94 ($873,191)
- 4 Open-market sale Chief Legal Officer sold 40,000 shares at $7.70 ($308,000)
- 4 Open-market sale Chief Financial Officer sold 95,741 shares at $7.00 ($670,187)
- 4 Open-market sale Chief Medical Officer sold 165,000 shares at an average $7.68 ($1,267,750)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 4,296 shares (option exercise)
- 4 Grant or award Director acquired 24,784 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 16 of 76 · 1,513 filings